Eagle Strategies LLC Pfizer Inc Transaction History

Eagle Strategies LLC

$522 Million
Q2 2024

A detailed history of Eagle Strategies LLC transactions in Pfizer Inc stock. As of the latest transaction made, Eagle Strategies LLC holds 13,363 shares of PFE stock, worth $396,346. This represents 0.07% of its overall portfolio holdings.

Number of Shares

13,363

Previous 10,624 25.78%

Holding current value

$396,346

Previous $294,000 26.87%

% of portfolio

0.07%

Previous 0.07%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$25.26 - $29.6 $69,187 - $81,074	2,739 Added 25.78%	13,363 $373,000
Q1 2024 Apr 22, 2024	BUY	$25.89 - $29.73 $4,401 - $5,054	170 Added 1.63%	10,624 $294,000
Q4 2023 Jan 26, 2024	SELL	$26.13 - $33.94 $5,356 - $6,957	-205 Reduced 1.92%	10,454 $300,000
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $30,485 - $35,634	-950 Reduced 8.18%	10,659 $353,000
Q2 2023 Aug 02, 2023	BUY	$36.12 - $41.79 $46,016 - $53,240	1,274 Added 12.33%	11,609 $425,000
Q1 2023 Apr 21, 2023	BUY	$39.39 - $51.28 $18,434 - $23,999	468 Added 4.74%	10,335 $421,000
Q4 2022 Feb 03, 2023	SELL	$41.75 - $54.5 $459 - $599	-11 Reduced 0.11%	9,867 $505,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $26,212 - $31,998	599 Added 6.46%	9,878 $432,000
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $52,206 - $61,900	-1,122 Reduced 10.79%	9,279 $487,000
Q1 2022 May 02, 2022	BUY	$45.75 - $56.69 $57,462 - $71,202	1,256 Added 13.73%	10,401 $538,000
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $377,871 - $560,131	9,145 New	9,145 $540,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Strategies LLC with notifications on news.

Account

Eagle Strategies LLC Pfizer Inc Transaction History